4TEEN4 Pharmaceuticals GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2002-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.4teen4.de
Procizumab (PCZ; AK1967) in Critical Cardiovascular Care
Phase 1
Not yet recruiting
- Conditions
- Shock, Cardiogenic
- Interventions
- Drug: AK1967 (Procizumab)Drug: Placebo
- First Posted Date
- 2025-02-18
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- 4TEEN4 Pharmaceuticals GmbH
- Target Recruit Count
- 130
- Registration Number
- NCT06832722
Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab)
Phase 1
Completed
- Conditions
- Safety and Tolerability
- Interventions
- Drug: AK1967 (Procizumab)Drug: Placebo
- First Posted Date
- 2024-03-26
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- 4TEEN4 Pharmaceuticals GmbH
- Target Recruit Count
- 24
- Registration Number
- NCT06331884
- Locations
- 🇳🇱
Radboud University Medical Center, Nijmegen, Gelderland, Netherlands
© Copyright 2025. All Rights Reserved by MedPath